Trademarkia Logo

Canada

C$
TEEWINOT
ABANDONED SECTION 36

on 22 Mar 2022

Last Applicant/ Owned by

TEEWINOT LIFE SCIENCES CORPORATION

12005 Whitmarsh LaneTampa, FL 33626

US

Serial Number

1930783 filed on 15th Nov 2018

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

TEEWINOT

Trademark usage description

pharmaceutical and biopharmaceutical drugs for the treatment of pain, inflammation, cancer, seizures, and epilepsy. custom manufacture of pharmaceuti Read More

Classification Information


Class [005]
Pharmaceutical and biopharmaceutical drugs for the treatment of pain, inflammation, cancer, seizures, and epilepsy.


Classification kind code

11

Class [040]
Custom manufacture of pharmaceuticals and biopharmaceutical drugs; Custom manufacturing of new biological products for others; Custom manufacture of chemical products for others; Custom manufacture of nutraceuticals for others; Custom manufacture of cosmeceuticals for others; Custom manufacture of medical veterinary products for others.


Classification kind code

11

Class [042]
Research and development of pharmaceuticals and biopharmaceutical drugs; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering, and organic chemistry; Research and development of new biological products for others; Research and development of new chemical products for others; Nutraceutical research and development for others; Cosmeceutical research and development for others; Veterinary medical research and development for others; Research and development in the field of bioinformatics and proteomics.


Classification kind code

11

Mark Details


Serial Number

1930783

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 22nd Mar 2022
Abandoned - Section 36
Submitted for opposition 14
on 4th Jan 2022
Default Notice Sent
Submitted for opposition 22
on 14th Jun 2021
Search Recorded
Submitted for opposition 20
on 14th Jun 2021
Examiner's First Report
Submitted for opposition 31
on 21st Nov 2018
Formalized
Submitted for opposition 1
on 16th Nov 2018
Created
Submitted for opposition 30
on 15th Nov 2018
Filed